Search

everythinglearnresearchcommunity

for

Search:↓

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Upadacitinib effectively treated severe hair loss in a child.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Denosumab treatment for osteoporosis can cause hair loss.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Pediatric alopecia areata needs better treatments and psychological support.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A man with severe hair loss regrew hair after hormone treatment.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.